- Transactions
- M&A / Private Equity
- The 14 June 2022
Yards advises XAnge, Omnes and Quantonation in the €16 million fundraising of Qubit Pharmaceuticals
BackLaw firm Yards advised Xange as well as Omnes and Quantonation in the €16 million fundraising of Qubit Pharmaceuticals, which was also subscribed by Octave Klaba (founder of OVH).
This fundraising operation will enable the company, which created a platform for the discovery of new treatments using quantum physics, to finance the building of its portfolio to ten research programmes on cancer and inflammatory diseases.
The Yards team consisted of Jean-Philippe Jacob, partner, Julien Brouwer, counsel, and Kamélia Kerchi, associate.
Keys Avocats and Altaïr Avocats acted as counsel to Qubit Pharmaceuticals.
Jeausserand Audouard acted as counsel to the founders of Qubit Pharmaceuticals.
Expertise
News M&A / Private Equity
-
- M&A / Private Equity
- Transactions
Yards advises the founders of Mipsology on its sale to AMD
-
- M&A / Private Equity
- Transactions
Yards advises Le Nouveau Bélier on the acquisition of a majority stake in Groupe Dékuple
-
- M&A / Private Equity
- Transactions
Yards advises the historic shareholders of Come to Paris on the sale of their stake to Butler Industries